Japanese Encephalitis Vaccine

Japanese encephalitis is a viral infection of the brain spread by infected Culex mosquitoes. Most infections cause no symptoms or a mild fever. In around one in 250 cases, the virus reaches the brain and causes encephalitis. Of those who develop encephalitis, 20 to 30 per cent die. A further 30 to 50 per cent of survivors are left with permanent neurological effects, including seizures, paralysis and cognitive impairment. There is no specific antiviral treatment once encephalitis develops. Vaccination and mosquito bite avoidance are the only reliable preventive measures.

The risk for urban tourists staying in hotels in cities and resort areas is considered low. Culex mosquitoes breed in rural standing water, and JE transmission in urban environments is rare. Risk rises significantly when travellers move into rural areas, particularly near rice-growing and farming land, travel during the local rainy season, or spend time outdoors in the evenings and at night. Vaccination is generally recommended if your itinerary includes substantial rural time, not for short city-based visits.

On the standard schedule, vaccination needs to begin at least five to six weeks before departure to ensure full protection by the time you travel. On the accelerated schedule, protection can be established within approximately two weeks of starting. Earlier is better: beginning vaccination well in advance allows more flexibility if appointments need to be rescheduled.

Side effects are generally mild. Headache is the most commonly reported reaction, occurring in a significant proportion of people after one or both doses. Soreness, redness or swelling at the injection site is also common. Mild fatigue or muscle aches may occur. Serious reactions are uncommon. Your clinician will discuss what to expect before administering the vaccine.

Yes. Ixiaro can be given at the same visit as most other travel vaccines. Your clinician will review your full travel itinerary and health history to confirm which vaccines are needed and whether any should be given at separate appointments.

If your primary course was completed more than two to three years ago and you are returning to an endemic area, a booster dose is recommended. If your previous vaccination was over ten years ago, a fresh primary course may be more appropriate. Your clinician will advise based on your vaccination records and planned travel.

Japanese encephalitis is present across a large part of Asia and the Western Pacific. At-risk countries include India (particularly Uttar Pradesh, Bihar and West Bengal), Nepal, Sri Lanka, Bangladesh, China, South Korea, Japan, Thailand, Vietnam, Cambodia, Laos, Myanmar, the Philippines and Indonesia. Risk is concentrated in rural areas, particularly near rice paddies and pig farms. In temperate zones, transmission peaks during and after the rainy season. In tropical parts of Southeast Asia, some risk exists year-round.

A full primary course consists of two doses of Ixiaro. On the standard schedule, the second dose is given 28 days after the first. On the accelerated schedule, available for adults aged 18 to 65, the second dose is given 7 days after the first. Full protection develops approximately one week after the second dose. A booster is recommended 12 to 24 months after the primary course for those who remain at risk.

The JE vaccine is not routinely offered on the NHS for travellers. Some specialist NHS travel clinics hold Ixiaro, but access is inconsistent and appointment availability can be limited, particularly during busy travel periods. For most travellers, private vaccination is the most reliable route to getting vaccinated in time.

The primary two-dose course provides protection for at least twelve to twenty-four months. A booster dose, given within that window, extends protection further. For those with continued exposure, such as expatriates or frequent travellers to endemic areas, further boosters may be given every ten years. Your clinician will advise on timing based on your travel plans and risk level.

Yes. Ixiaro is licensed for use from two months of age. Children aged two months to less than three years receive a lower dose; those aged three and over receive the same dose as adults. Note that the accelerated 7-day schedule is only for adults aged 18 to 65. Children must follow the standard 28-day schedule. Please let us know when booking that you are bringing a child.

Mosquito avoidance measures, including DEET-based repellent, long-sleeved clothing from dusk onwards, and sleeping under a treated net, reduce exposure significantly but cannot eliminate risk entirely. Culex mosquitoes are active throughout the night, and in rural areas some contact is difficult to avoid completely. For those at significant risk, vaccination combined with bite avoidance provides greater protection than either measure alone.